OR WAIT null SECS
Ramesh Raju Mavuleti*, rrajum@gmail.com, is head of operations, Validation Services India, at Merck Life Sciences Pvt, Ltd.
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
The evolution of therapeutic modalities drives the adoption of single-use technologies.